Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL614245 Target Snapshot

THP-1 · CELL-LINE · Homo sapiens

8,236Compounds
2,329Assays
59Approved Drugs
5,105.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-13

Confirm a stable target identifier before relying on this context across project surfaces.

Review focus
Open DB context pending

Confirm a stable target identifier before relying on this context across project surfaces.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-13
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats THP-1 as ChEMBL target CHEMBL614245. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
THP-1
CELL-LINE · Homo sapiens
As of 2026-09-13
ChEMBL target ID
CHEMBL614245
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-13
www.ebi.ac.uk
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-13
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether THP-1 still has a stable protein naming contract across sources.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelTHP-1
UniProt AccessionN/A

THP-1

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as THP-1.

Review nameTHP-1
OrganismHomo sapiens
Clinical Profile

Clinical Phase Distribution

59
Approved
17
Phase III
31
Phase II
8
Phase I
Assay Mix

Activity Type Distribution

IC504,501.0
KI1.0
EC50603.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL4636181 10.0 IC50 0.1 Preclinical
CHEMBL432374 9.96 IC50 0.11 Preclinical
CHEMBL4649732 9.9 IC50 0.1259 Preclinical
CHEMBL3893393 9.8 IC50 0.1585 Preclinical
CHEMBL4638451 9.7 IC50 0.1995 Preclinical
CHEMBL328242 9.7 IC50 0.2 Preclinical
CHEMBL5618885 9.52 IC50 0.3 Preclinical
CHEMBL1092012 9.52 IC50 0.3 Preclinical
CHEMBL419134 9.52 IC50 0.3 Preclinical
CHEMBL2170284 9.43 IC50 0.37 Preclinical
Distribution

pChEMBL Value Distribution

502
5.0
426
5.5
405
6.0
353
6.5
286
7.0
163
7.5
124
8.0
71
8.5
51
9.0
8
9.5
pChEMBL
Approved Drugs

Approved Drugs

QUIZARTINIB
CHEMBL576982
Approved 2023
ABEMACICLIB
CHEMBL3301610
Approved 2017
VENETOCLAX
CHEMBL3137309
Approved 2016
PANOBINOSTAT
CHEMBL483254
Approved 2015
BELINOSTAT
CHEMBL408513
Approved 2014
TOFACITINIB
CHEMBL221959
Approved 2012
NILOTINIB
CHEMBL255863
Approved 2007
SUNITINIB
CHEMBL535
Approved 2006
VORINOSTAT
CHEMBL98
Approved 2006
SORAFENIB
CHEMBL1336
Approved 2005
GEMCITABINE
CHEMBL888
Approved 1996
VINORELBINE
CHEMBL553025
Approved 1994
PACLITAXEL
CHEMBL428647
Approved 1992
ETOPOSIDE
CHEMBL44657
Approved 1983
MITOMYCIN
CHEMBL105
Approved 1981
PROBUCOL
CHEMBL608
Approved 1977
DOXORUBICIN
CHEMBL53463
Approved 1974
THIOGUANINE
CHEMBL727
Approved 1966
INDOMETHACIN
CHEMBL6
Approved 1965
FLUOROURACIL
CHEMBL185
Approved 1962
BETAMETHASONE
CHEMBL632
Approved 1961
COLCHICINE
CHEMBL107
Approved 1961
DEXAMETHASONE
CHEMBL384467
Approved 1958
DISULFIRAM
CHEMBL964
Approved 1951
Assay Landscape

Assay Landscape

2,331
Total Assays
2,568
Tested Compounds
3
Assay Types
Functional — 1,833 assays, 2,568 compounds
BAO Format Assays Compounds Avg pChEMBL
cell-based format 1,824 2,568 6.2
organism-based format 8 0
cell-free format 1 0
ADME — 379 assays, 562 compounds
BAO Format Assays Compounds Avg pChEMBL
cell-based format 374 562 4.8
organism-based format 5 0
Toxicity — 119 assays, 67 compounds
BAO Format Assays Compounds Avg pChEMBL
cell-based format 119 67 4.8

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine